BRCA2 and ovarian carcinoma: In a large study, LGRs were reported to constitute around 24% of BRCA1/BRCA2 PVs in high-risk breast/ovarian cancer families, [55] while lower rates are reported in other series and in individuals without strong family histories [53,55,56].